Enzymatic activity of the second component of complement
- PMID: 241376
- DOI: 10.1021/bi00690a015
Enzymatic activity of the second component of complement
Abstract
Isolated C2 and C2i preparations were able to hydrolyze a number of synthetic esters containing basic amino acids, among which N-alpha-acetylglycyl-L-lysine methyl ester (AcGlyLysOMe) was most susceptible. The cleaving activity was a property of the C2 molecule, since it correlated with the presence of C2 on analyses of C2 preparations by ultracentrifugation in sucrose gradients, filtration through Sephadex G-200 columns, and on electrophoresis in acrylamide gels. Furthermore, acrylamide gel electrophoretic studies showed a shift in hydrolytic activity from the position occupied by C2 to that characteristic of C2i after incubation of C2 with C1s. The action was enzymatically mediated as evidenced by a bell-shaped pH activity curve, a linear dependence on C2 concentration, and the presence of Michaelis-Menten kinetics. The Michaelis constant for cleavage of AcGlyLysOMe by C2 was 1.8 X 10(-2) mol. Cleavage of C2 by C1s increased C2 enzymatic activity, yet chemical oxidation of the molecule, although enhancing hemolytic acitivity, failed to increase C2 hydrolytic activity. The observed enzymatic activity of C2 was found to be relevant to the function of C2 in the C42 complex, since AcGlyLysOMe competitively inhibited the C42 mediated cleavage of C3 in free solution and the C42 dependent binding of C3 to cells.
Similar articles
-
Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.Proc Natl Acad Sci U S A. 1977 Jul;74(7):2998-3001. doi: 10.1073/pnas.74.7.2998. Proc Natl Acad Sci U S A. 1977. PMID: 70787 Free PMC article.
-
Complement C2 receptor inhibitor trispanning and the beta-chain of C4 share a binding site for complement C2.J Immunol. 2002 May 15;168(10):5213-21. doi: 10.4049/jimmunol.168.10.5213. J Immunol. 2002. PMID: 11994478
-
Functional analysis of activated C1s, a subcomponent of the first component of human complement, by monoclonal antibodies.J Immunol. 1986 Nov 1;137(9):2907-12. J Immunol. 1986. PMID: 2428878
-
The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.Rheumatology. 1975;6:2-16. Rheumatology. 1975. PMID: 1105744 Review. No abstract available.
-
Structure and activation of the early components of complement.Fed Proc. 1977 Aug;36(9):2191-6. Fed Proc. 1977. PMID: 328305 Review. No abstract available.
Cited by
-
The purification and properties of the second component of human complement.Biochem J. 1978 Apr 1;171(1):99-107. doi: 10.1042/bj1710099. Biochem J. 1978. PMID: 417728 Free PMC article.
-
Isolation of cDNA clones for human complement component C2.Proc Natl Acad Sci U S A. 1984 Feb;81(4):1212-5. doi: 10.1073/pnas.81.4.1212. Proc Natl Acad Sci U S A. 1984. PMID: 6199794 Free PMC article.
-
Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.Biochem J. 1979 Dec 1;183(3):615-22. doi: 10.1042/bj1830615. Biochem J. 1979. PMID: 261515 Free PMC article.
-
The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.Biochem J. 1986 May 1;235(3):723-30. doi: 10.1042/bj2350723. Biochem J. 1986. PMID: 3638964 Free PMC article.
-
Loa loa Microfilariae evade complement attack in vivo by acquiring regulatory proteins from host plasma.Infect Immun. 2009 Sep;77(9):3886-93. doi: 10.1128/IAI.01583-08. Epub 2009 Jun 15. Infect Immun. 2009. PMID: 19528206 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous